Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

1Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Autoimmune blistering skin disease (AIBD) is a term used to describe a heterogeneous group of cutaneous and mucosal diseases with significant morbidity and mortality. A range of ocular complications can occur in patients with AIBD, due to the underlying blistering disease or as side effects of the medications used to treat these diseases. The most common ocular presentation of AIBD is a chronic conjunctivitis, which can progress to conjunctival fibrosis and eventually chronic cicatricial conjunctivitis. Cicatrisation leads to ocular complications that include symblepharon, fornix foreshortening, entropion, trichiasis, corneal damage and neovascularisation. Clinical features in the eye overlap between the types of AIBD. Early recognition and treatment of the disease is essential to prevent irreversible scarring and progression to blindness in certain cases.

Cite

CITATION STYLE

APA

Eskin-Schwartz, M., & Mimouni, D. (2015). Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases. In Blistering Diseases: Clinical Features, Pathogenesis, Treatment (pp. 483–491). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-45698-9_48

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free